Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  42.00 2.15% 2,000.00 2,000.00 2,005.00 2,030.00 1,942.00 1,974.00 278,721 16:29:58
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Retailers 427.8 9.9 8.1 246.9 1,415

Cvs Share Discussion Threads

Showing 651 to 674 of 675 messages
Chat Pages: 27  26  25  24  23  22  21  20  19  18  17  16  Older
DateSubjectAuthorDiscuss
01/4/2021
22:00
Smacks more of profit taking. Annoying
robertball
01/4/2021
16:56
I'm not sure, but it is annoying
capitalist
30/3/2021
08:38
Big seller?
robertball
26/3/2021
16:29
Quite so. Could see more profit-taking first though : even at around £18 it would still be in its uptrend .
dogwalker
26/3/2021
16:16
Good entry point then? As don't see why it shouldn't return back to 20s
jonojubb
26/3/2021
15:33
I would say 'yes' to that !
dogwalker
26/3/2021
14:50
Profit taking to blame for the sharp drop?
jonojubb
26/3/2021
13:26
CVS Group plc H1 2021 Results Presentation, given by Richard Fairman, CEO, Robin Alfonso, CFO and Ben Jacklin, COO on 25th March 2021 Watch the video here: Https://www.piworld.co.uk/2021/03/26/cvs-group-cvsg-h1-analyst-presentation-given-25-3-21/ Or listen to the podcast version here: Https://piworld.podbean.com/e/cvs-group-cvsg-h1-analyst-presentation-given-25321/
tomps2
26/3/2021
10:59
A change of senior management appears to have revitalised CVS. The expanding pet population over lockdown should also be good news for its long-term growth prospects. Investor's Champion's in-depth commentary covers the latest results and its considerable appeal (IHT qualifying)
energeticbacker
25/3/2021
11:44
Vets having a good year and a good stock of animals to treat going forward. Companion animals going to cause a boom in sales as they age.....can’t beat the demographics (if that is the appropriate term referencing pets).
whatja
25/3/2021
10:26
Solid uptrend, great reaction to news and most importantly a dead quiet board - as good as it gets in this game
davr0s
02/2/2021
16:49
I would add dechra pharmaceuticals to the IC list. Has grown steadily and consistently. Doubled my investment over 5 years....never had a serious down in that time.
whatja
01/2/2021
12:46
CVS Group announced a strong financial performance for the 6 months to 31 December 2020 with sales up 9.4% to £245.6m, of which like-for-like sales increased by 7.8%. That is a terrific performance over a very tricky period, highlighting the resilience of this growing sector. More detail on Investor's Champion's website.
energeticbacker
21/12/2020
10:26
The growth in pet ownership over lockdown and owner’s desires to keep their pets fit and healthy has been great news for the pet care sector. However, who are going to be the long-term winners from the current pet boom? Investor’s Champion’s research highlights some terrific companies which should continue to do well, including a star performer. #ancr #chwy #cvsg #elan #idxx #nesn #pets #zts
energeticbacker
26/11/2020
19:16
Pleased with progress, already a very LTBH for me.
lomax99
26/11/2020
17:39
Another great update covered by long term supporter Investor's Champion in their latest update
energeticbacker
26/11/2020
15:08
Oh ok. See what you mean. A different view : a temporary moderating of enthusiasm. On a more usual timeframe, e.g. on a daily basis,the shares look very bullish .
dogwalker
26/11/2020
14:03
Price reversed rather sharpishly. Not the strong response I was expecting where it'd open up and steadily drift higher throughout the day.
from8to800
26/11/2020
13:01
Massive u turn. Bad sign.
from8to800
22/11/2020
16:07
Generally true in a lot of cases Diku.
luderitz
21/11/2020
13:19
You know when Private Equity guys bring company to market...the juice has been sucked out...and PI's generally hung up high and dry...
diku
21/11/2020
13:04
I’m sticking with cvsg
1jat
20/11/2020
16:52
FT Lombard today: IPO for vet services group IVC is likely to test the market’s animal spirits Lockdown Britain has a puppy shortage and a surfeit of stock market dogs. Veterinary services company IVC Evidensia, a beneficiary of the former, has all the makings of the latter. Private Equity group EQT and Nestle, IVC’s current owners, are planning a London listing for early next year. They see a business worth up to £12bn at the enterprise value level, at least according to excitable bankers who have attached themselves to the plan. Investor might ask what exactly has changed since IVC’s funding round in February last year, which set the headline enterprise value at just £3bn. The answer appears obvious. Homeworking has given time-poor commuters the opportunity of pet ownership. Google Trends data picked up a doubling of UK searches for “vets near me” in the five months after the March lockdown as new owners looked to vaccinate and neuter their new companion. Pets being for life, the trend is likely to withstand recession. Like-for-like sales at CVS, the UK listed vet owner, hardly budged throughout the downturn of 2007 to 2011. Its shares have surged more than six-fold from March lows on expectations of a repeat performance. CVS and its private equity-backed rivals take advantage of industry economics that favour buying over building. They buy up independent practices with long customer lists then use scale to squeeze down costs. When the time comes to sell, consolidators such as the US behemoth Mars Petcare have been rapacious customers. The playbook has limits, however, mandatory services such as 24-hour locums are a cap on cost cutting potential so earnings can flatline soon after acquisition. Analysis from RBC Capital Markets found the between 2009 and 2017 CVS bought £26.1m of ebitda by taking over 255 practices, yet group ebitda rose by just £29.7m. While not much is known yet about IVC’s finances, a Fitch report from August hints as a roll-up vehicle that is running out of road. The debt rating agency expects sales to grow just 5 per cent by 2024 and records negative fee cash flow for 2019 as net debt ballooned to 9 time ebitda, likely choking the bid pipeline. Perhaps lockdown has transformed these numbers but if that is the case, why would the sellers be selling? London needs to shake its reputation for overhyped floats, particularly those that give private equity a timely exit. If an IVC arrives anywhere close to its mooted valuation, investors are being served another dog’s dinner.
lomax99
09/11/2020
17:08
It has been a topsy turvy day. CVSG has been relatively stable.....So maybe these are sold to chase the Covid shares that might gain.
whatja
Chat Pages: 27  26  25  24  23  22  21  20  19  18  17  16  Older
ADVFN Advertorial
Your Recent History
LSE
CVSG
Cvs
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210417 12:20:52